RxDoctor Payments Data

Lisa Cohen

Family Medicine · Palm Harbor, FLNPI 1750348058

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $72 of the $92 with a category attached, or 78.2%. 3 manufacturers reported payments, led by Novo Nordisk at 40.2% of the total. That places this record below the midpoint for family medicine clinicians in FL, where the typical reported total is $424.

$92in general payments, 2019–2025

Across 4 payments — averaging $22.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$37
  • Merck$35
  • Pfizer$20
$12,273,729in research payments, 2019–2025

Across 1,349 payments — averaging $9098.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$5.7M
  • Modernatx, Inc.$2.7M
  • Merck$988K
  • Seqirus USA Inc$786K
  • Emergent Biosolutions Inc.$748K
  • Bavarian Nordic A/s$477K
  • plus $962K from 15 others

What the payments were for

  • Food & beverage$7278%
  • Gifts$2022%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk2$37
Merck1$35
Pfizer1$20

How this compares

$92 in reported general payments places this provider in the 20th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Other family medicine in Palm Harbor

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →